SKP2 and neoplasm: Katagiri et al. reported that knockdown of Skp2 inhibited the melanoma cell growth in vitro and suppressed tumor proliferation in vivo, suggesting that gene silencing of Skp2 can be a potential tool of cancer gene therapy in malignant melanoma [51].